Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations

Clinical trial NCT05229588 · COMPLETED

Trial details

NCT number: NCT05229588
Sponsor: HonorHealth Research Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Malignancies

Start date: 2022-06-14
Primary completion: 2025-08-04
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.